Protocol for preparation of allelic exchange parasites
Allelic exchange constructs were based on the pPM2GT vector (doi: 10.1083/jcb200307147). A C-terminal fragment of the ORF of PF3D7_0107500 was amplified using the primers ARF-F (CACTATAGAACTCGAGCCATCAAAAATTGTATCTATGGAAG) and ARF-R (CTGCACCTGGCCTAGGATGTAGTGGGCCAAAACTGGAAAGAAG). The pPM2GT vector was digested with XhoI and AvrII and gel purified. The PCR product was cloned into the digested pPM2GT vector using Infusion cloning (Takara Bio). The sequence of the construct was confirmed by Sanger sequencing. Using this strategy pfncr1 is expressed from the endogenous promoter in-frame with a C-terminal GFP (the native stop is deleted). When desired, mutations were introduced into the pfncr1 wild-type containing pPM2GT clone. Mutations typically contained changes to create compound-resistant parasites. Transfections were performed in duplicate using 100 mg of supercoiled DNA with 3D7 ring-stage parasites containing 10% parasites. To select for transfected parasites, 5 nM WR99210 was added to mature ring-stage parasites one cycle after transfection. Once transfectants grew, parasite cultures were cycled off for three weeks. Next WR99210 was reapplied until parasites grew well. The off-drug cycle was repeated for a second time to enrich for transfected parasites. Finally, transfectants were cloned by limited dilution.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.